NO20073610L - Nye substituerte tiofenpyrimidinonderivater som inhibitorer for 17 β-hydroksysteroiddehydrogenase - Google Patents
Nye substituerte tiofenpyrimidinonderivater som inhibitorer for 17 β-hydroksysteroiddehydrogenaseInfo
- Publication number
- NO20073610L NO20073610L NO20073610A NO20073610A NO20073610L NO 20073610 L NO20073610 L NO 20073610L NO 20073610 A NO20073610 A NO 20073610A NO 20073610 A NO20073610 A NO 20073610A NO 20073610 L NO20073610 L NO 20073610L
- Authority
- NO
- Norway
- Prior art keywords
- derivatives
- hydroxysteroid dehydrogenase
- thiophenpyrimidinone
- inhibitors
- newly substituted
- Prior art date
Links
- 108010070743 3(or 17)-beta-hydroxysteroid dehydrogenase Proteins 0.000 title abstract 2
- 102100034067 Dehydrogenase/reductase SDR family member 11 Human genes 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 4
- 230000001419 dependent effect Effects 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 239000003270 steroid hormone Substances 0.000 abstract 2
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2004/053424 WO2006063615A1 (en) | 2004-12-13 | 2004-12-13 | NOVEL SUBSTITUTED THIOPHENEPYRIMIDINONE DERIVATIVES AS INHIBITORS OF 17β-HYDROXYSTEROID DEHYDROGENASE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20073610L true NO20073610L (no) | 2007-09-12 |
Family
ID=34959788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20073610A NO20073610L (no) | 2004-12-13 | 2007-07-12 | Nye substituerte tiofenpyrimidinonderivater som inhibitorer for 17 β-hydroksysteroiddehydrogenase |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1828197B1 (pl) |
| JP (1) | JP4686549B2 (pl) |
| CN (1) | CN101087793B (pl) |
| AT (1) | ATE431351T1 (pl) |
| AU (1) | AU2004325692B2 (pl) |
| BR (1) | BRPI0419229A (pl) |
| CA (1) | CA2590233A1 (pl) |
| DE (1) | DE602004021145D1 (pl) |
| ES (1) | ES2327240T3 (pl) |
| MX (1) | MX2007007051A (pl) |
| NO (1) | NO20073610L (pl) |
| PL (1) | PL1828197T3 (pl) |
| WO (1) | WO2006063615A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8080540B2 (en) | 2006-09-19 | 2011-12-20 | Abbott Products Gmbh | Therapeutically active triazoles and their use |
| TW201520219A (zh) * | 2013-03-12 | 2015-06-01 | Lilly Co Eli | 咪唑並吡啶化合物 |
| BR112016015578A2 (pt) | 2014-01-03 | 2017-08-08 | Elexopharm Gmbh | Inibidores de 17beta-hidroxiesteroide desidrogenases tipo 1 e tipo 2 |
| KR20250003936A (ko) * | 2022-04-28 | 2025-01-07 | 이난타 파마슈티칼스, 인코포레이티드 | 피리미디논 함유 17-베타-하이드록시스테로이드 탈수소효소 유형 13 억제제 |
| CN120114459B (zh) * | 2025-05-14 | 2025-07-29 | 南京工业大学 | 苯并呋喃嘧啶酮或苯并噻吩嘧啶酮类化合物的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4054656A (en) * | 1975-09-10 | 1977-10-18 | Mead Johnson & Company | Thieno[2,3-d]pyrimidine antiallergic agents |
| JPS62132884A (ja) * | 1985-12-05 | 1987-06-16 | Mitsubishi Chem Ind Ltd | ２−ベンジルチエノ〔２，３−ｄ〕ピリミジン−４（３Ｈ）−オン誘導体 |
| US5124331A (en) * | 1988-03-02 | 1992-06-23 | Yoshitomi Pharmaceutical Industries, Ltd. | 3,4-dihydrothieno[2,3-d]pyrimidine compounds and their pharmaceutical use |
| US5597823A (en) * | 1995-01-27 | 1997-01-28 | Abbott Laboratories | Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists |
| FI20030393A7 (fi) * | 2003-03-14 | 2004-09-15 | Molekyyliendokrinologian Tutkimusyksikkoe | Menetelmiä, joilla voidaan ennustaa rintasyövän kehistyskulku ja yhdisteitä, joita voidaan käyttää sen ehkäisemiseksi tai hoitamiseksi |
| US7754709B2 (en) * | 2003-06-10 | 2010-07-13 | Solvay Pharmaceuticals Bv | Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds |
| US7465739B2 (en) * | 2003-06-10 | 2008-12-16 | Solvay Pharmaceuticals B.V. | Compounds and their use in therapy |
-
2004
- 2004-12-13 JP JP2007545846A patent/JP4686549B2/ja not_active Expired - Fee Related
- 2004-12-13 AT AT04804787T patent/ATE431351T1/de not_active IP Right Cessation
- 2004-12-13 CN CN200480044596XA patent/CN101087793B/zh not_active Expired - Fee Related
- 2004-12-13 EP EP04804787A patent/EP1828197B1/en not_active Expired - Lifetime
- 2004-12-13 AU AU2004325692A patent/AU2004325692B2/en not_active Expired - Fee Related
- 2004-12-13 WO PCT/EP2004/053424 patent/WO2006063615A1/en not_active Ceased
- 2004-12-13 ES ES04804787T patent/ES2327240T3/es not_active Expired - Lifetime
- 2004-12-13 BR BRPI0419229-0A patent/BRPI0419229A/pt not_active IP Right Cessation
- 2004-12-13 MX MX2007007051A patent/MX2007007051A/es active IP Right Grant
- 2004-12-13 CA CA002590233A patent/CA2590233A1/en not_active Abandoned
- 2004-12-13 PL PL04804787T patent/PL1828197T3/pl unknown
- 2004-12-13 DE DE602004021145T patent/DE602004021145D1/de not_active Expired - Lifetime
-
2007
- 2007-07-12 NO NO20073610A patent/NO20073610L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL1828197T3 (pl) | 2009-11-30 |
| JP2008523117A (ja) | 2008-07-03 |
| DE602004021145D1 (de) | 2009-06-25 |
| BRPI0419229A (pt) | 2007-12-18 |
| ATE431351T1 (de) | 2009-05-15 |
| WO2006063615A1 (en) | 2006-06-22 |
| EP1828197B1 (en) | 2009-05-13 |
| ES2327240T3 (es) | 2009-10-27 |
| AU2004325692A1 (en) | 2006-06-22 |
| AU2004325692B2 (en) | 2012-01-19 |
| CA2590233A1 (en) | 2006-06-22 |
| CN101087793B (zh) | 2011-09-07 |
| EP1828197A1 (en) | 2007-09-05 |
| MX2007007051A (es) | 2007-06-26 |
| CN101087793A (zh) | 2007-12-12 |
| JP4686549B2 (ja) | 2011-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200509937A (en) | Novel compounds and their use in therapy | |
| WO2008034796A3 (en) | Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors | |
| WO2006023544A3 (en) | Therapeutic uses of inhibitors of rtp801 | |
| MXPA05013224A (es) | Piridinilcarbamatos como inhibidores de lipasa sensible a hormonas. | |
| MY148480A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| WO2007061661A3 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| NO20076616L (no) | 17beta-HSD1- og STS-inhibitorer | |
| EA200800006A1 (ru) | Триазолопиридины в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы типа i | |
| DK1809280T3 (da) | Mitotiske kinesininhibitorer og fremgangsmåder til anvendelse deraf | |
| TNSN07161A1 (en) | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
| WO2007141796A3 (en) | Therapeutic uses of inhibitors of rtp801l | |
| TW200806325A (en) | Therapeutic uses of inhibitors of RTP801 | |
| BRPI0411319A (pt) | compostos terapeuticamente ativos e sua utilização | |
| NO20083836L (no) | N-hydroksyakrylamidforbindelser | |
| WO2005084654A3 (en) | Methods and compositions for treating or preventing psychiatric disorders with cox-2 inhibitors alone and in combination with antidepressant agents | |
| WO2009009417A3 (en) | Pharmaceutical compositions and methods of preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion | |
| WO2006074265A3 (en) | Drug combination therapy and pharmaceutical compositions for treating inflammatory disorders | |
| TW200602325A (en) | Heterocyclylacetic acids as inhibitors of TAFIa | |
| BRPI0506970B8 (pt) | derivados de alfa-aminoamida úteis no tratamento de distúrbios do trato urinário inferior | |
| NO20073610L (no) | Nye substituerte tiofenpyrimidinonderivater som inhibitorer for 17 β-hydroksysteroiddehydrogenase | |
| MXPA05013226A (es) | Carbamatos de piperidina sustituidos, para el uso como inhibidores de la lipasa sensible a hormonas. | |
| WO2006023866A3 (en) | Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1 | |
| IL179206A0 (en) | Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same | |
| NO20071466L (no) | 3-substituerte-5- og 6-aminoalkyl indol-2-karboksylsyreamider og relaterte analoger som inhibitorer av kaseinkinase IE | |
| DK1784173T3 (da) | Farmaceutisk sammensætning til forebyggelse og behandling af metaboliske knoglesygdomme indeholdende alpha-arylmethoxyacrylatderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |